122 related articles for article (PubMed ID: 25728942)
1. Do different decision-analytic modeling approaches produce different results? A systematic review of cross-validation studies.
Tsoi B; Goeree R; Jegathisawaran J; Tarride JE; Blackhouse G; O'Reilly D
Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):451-63. PubMed ID: 25728942
[TBL] [Abstract][Full Text] [Related]
2. Systematic narrative review of decision frameworks to select the appropriate modelling approaches for health economic evaluations.
Tsoi B; O'Reilly D; Jegathisawaran J; Tarride JE; Blackhouse G; Goeree R
BMC Res Notes; 2015 Jun; 8():244. PubMed ID: 26081877
[TBL] [Abstract][Full Text] [Related]
3. Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer's Disease.
Hernandez L; Ozen A; DosSantos R; Getsios D
Pharmacoeconomics; 2016 Jul; 34(7):681-707. PubMed ID: 26899832
[TBL] [Abstract][Full Text] [Related]
4. Systematic assessment of decision-analytic models for chronic myeloid leukemia.
Rochau U; Schwarzer R; Jahn B; Sroczynski G; Kluibenschaedl M; Wolf D; Radich J; Brixner D; Gastl G; Siebert U
Appl Health Econ Health Policy; 2014 Apr; 12(2):103-15. PubMed ID: 24385259
[TBL] [Abstract][Full Text] [Related]
5. The role of decision analytic modeling in the health economic assessment of spinal intervention.
Edwards NC; Skelly AC; Ziewacz JE; Cahill K; McGirt MJ
Spine (Phila Pa 1976); 2014 Oct; 39(22 Suppl 1):S16-42. PubMed ID: 25299257
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of decision analytic modeling techniques for the economic evaluation of dental caries interventions.
Qu Z; Zhang S; Krauth C; Liu X
PLoS One; 2019; 14(5):e0216921. PubMed ID: 31091279
[TBL] [Abstract][Full Text] [Related]
7. Simple Inclusion of Complex Diagnostic Algorithms in Infectious Disease Models for Economic Evaluation.
Dodd PJ; Pennington JJ; Bronner Murrison L; Dowdy DW
Med Decis Making; 2018 Nov; 38(8):930-941. PubMed ID: 30403578
[TBL] [Abstract][Full Text] [Related]
8. AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users.
Vemer P; Corro Ramos I; van Voorn GA; Al MJ; Feenstra TL
Pharmacoeconomics; 2016 Apr; 34(4):349-61. PubMed ID: 26660529
[TBL] [Abstract][Full Text] [Related]
9. Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section.
Cooper NJ; Sutton AJ; Abrams KR
Stat Methods Med Res; 2002 Dec; 11(6):491-512. PubMed ID: 12516986
[TBL] [Abstract][Full Text] [Related]
10. Decision-analytic modeling studies: An overview for clinicians using multiple myeloma as an example.
Rochau U; Jahn B; Qerimi V; Burger EA; Kurzthaler C; Kluibenschaedl M; Willenbacher E; Gastl G; Willenbacher W; Siebert U
Crit Rev Oncol Hematol; 2015 May; 94(2):164-78. PubMed ID: 25620327
[TBL] [Abstract][Full Text] [Related]
11. ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions.
Jauregui B; Janusz CB; Clark AD; Sinha A; Garcia AG; Resch S; Toscano CM; Sanderson C; Andrus JK
Vaccine; 2015 May; 33 Suppl 1():A21-7. PubMed ID: 25919164
[TBL] [Abstract][Full Text] [Related]
12. Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer.
de Boer PT; Frederix GW; Feenstra TL; Vemer P
Pharmacoeconomics; 2016 Sep; 34(9):833-45. PubMed ID: 27129572
[TBL] [Abstract][Full Text] [Related]
13. Decision analytic modeling in spinal surgery: a methodologic overview with review of current published literature.
McAnany SJ; Anwar MA; Qureshi SA
Spine J; 2015 Oct; 15(10):2254-70. PubMed ID: 26111597
[TBL] [Abstract][Full Text] [Related]
14. [Decision analytic modeling and their impact on health care decision making].
Inotai A; Kaló Z; Mészáros A
Acta Pharm Hung; 2009; 79(2):63-9. PubMed ID: 19634636
[TBL] [Abstract][Full Text] [Related]
15. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
[TBL] [Abstract][Full Text] [Related]
16. A Systematic Review of Health Economics Simulation Models of Chronic Obstructive Pulmonary Disease.
Zafari Z; Bryan S; Sin DD; Conte T; Khakban R; Sadatsafavi M
Value Health; 2017 Jan; 20(1):152-162. PubMed ID: 28212957
[TBL] [Abstract][Full Text] [Related]
17. Health economic evaluations using decision analytic modeling. Principles and practices--utilization of a checklist to their development and appraisal.
Soto J
Int J Technol Assess Health Care; 2002; 18(1):94-111. PubMed ID: 11987445
[TBL] [Abstract][Full Text] [Related]
18. Why should we apply ABM for decision analysis for infectious diseases?-An example for dengue interventions.
Miksch F; Jahn B; Espinosa KJ; Chhatwal J; Siebert U; Popper N
PLoS One; 2019; 14(8):e0221564. PubMed ID: 31454373
[TBL] [Abstract][Full Text] [Related]
19. Estimation of Survival Probabilities for Use in Cost-effectiveness Analyses: A Comparison of a Multi-state Modeling Survival Analysis Approach with Partitioned Survival and Markov Decision-Analytic Modeling.
Williams C; Lewsey JD; Mackay DF; Briggs AH
Med Decis Making; 2017 May; 37(4):427-439. PubMed ID: 27698003
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
